Cargando…
Multinuclear MRI in Drug Discovery
The continuous development of magnetic resonance imaging broadens the range of applications to newer areas. Using MRI, we can not only visualize, but also track pharmaceutical substances and labeled cells in both in vivo and in vitro tests. (1)H is widely used in the MRI method, which is determined...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572840/ https://www.ncbi.nlm.nih.gov/pubmed/36235031 http://dx.doi.org/10.3390/molecules27196493 |
_version_ | 1784810717311926272 |
---|---|
author | Bartusik-Aebisher, Dorota Bober, Zuzanna Zalejska-Fiolka, Jolanta Kawczyk-Krupka, Aleksandra Aebisher, David |
author_facet | Bartusik-Aebisher, Dorota Bober, Zuzanna Zalejska-Fiolka, Jolanta Kawczyk-Krupka, Aleksandra Aebisher, David |
author_sort | Bartusik-Aebisher, Dorota |
collection | PubMed |
description | The continuous development of magnetic resonance imaging broadens the range of applications to newer areas. Using MRI, we can not only visualize, but also track pharmaceutical substances and labeled cells in both in vivo and in vitro tests. (1)H is widely used in the MRI method, which is determined by its high content in the human body. The potential of the MRI method makes it an excellent tool for imaging the morphology of the examined objects, and also enables registration of changes at the level of metabolism. There are several reports in the scientific publications on the use of clinical MRI for in vitro tracking. The use of multinuclear MRI has great potential for scientific research and clinical studies. Tuning MRI scanners to the Larmor frequency of a given nucleus, allows imaging without tissue background. Heavy nuclei are components of both drugs and contrast agents and molecular complexes. The implementation of hyperpolarization techniques allows for better MRI sensitivity. The aim of this review is to present the use of multinuclear MRI for investigations in drug delivery. |
format | Online Article Text |
id | pubmed-9572840 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95728402022-10-17 Multinuclear MRI in Drug Discovery Bartusik-Aebisher, Dorota Bober, Zuzanna Zalejska-Fiolka, Jolanta Kawczyk-Krupka, Aleksandra Aebisher, David Molecules Review The continuous development of magnetic resonance imaging broadens the range of applications to newer areas. Using MRI, we can not only visualize, but also track pharmaceutical substances and labeled cells in both in vivo and in vitro tests. (1)H is widely used in the MRI method, which is determined by its high content in the human body. The potential of the MRI method makes it an excellent tool for imaging the morphology of the examined objects, and also enables registration of changes at the level of metabolism. There are several reports in the scientific publications on the use of clinical MRI for in vitro tracking. The use of multinuclear MRI has great potential for scientific research and clinical studies. Tuning MRI scanners to the Larmor frequency of a given nucleus, allows imaging without tissue background. Heavy nuclei are components of both drugs and contrast agents and molecular complexes. The implementation of hyperpolarization techniques allows for better MRI sensitivity. The aim of this review is to present the use of multinuclear MRI for investigations in drug delivery. MDPI 2022-10-01 /pmc/articles/PMC9572840/ /pubmed/36235031 http://dx.doi.org/10.3390/molecules27196493 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Bartusik-Aebisher, Dorota Bober, Zuzanna Zalejska-Fiolka, Jolanta Kawczyk-Krupka, Aleksandra Aebisher, David Multinuclear MRI in Drug Discovery |
title | Multinuclear MRI in Drug Discovery |
title_full | Multinuclear MRI in Drug Discovery |
title_fullStr | Multinuclear MRI in Drug Discovery |
title_full_unstemmed | Multinuclear MRI in Drug Discovery |
title_short | Multinuclear MRI in Drug Discovery |
title_sort | multinuclear mri in drug discovery |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572840/ https://www.ncbi.nlm.nih.gov/pubmed/36235031 http://dx.doi.org/10.3390/molecules27196493 |
work_keys_str_mv | AT bartusikaebisherdorota multinuclearmriindrugdiscovery AT boberzuzanna multinuclearmriindrugdiscovery AT zalejskafiolkajolanta multinuclearmriindrugdiscovery AT kawczykkrupkaaleksandra multinuclearmriindrugdiscovery AT aebisherdavid multinuclearmriindrugdiscovery |